Evidence map›Paper›PMID 41329311›Full record

ArticleAnnals of surgical oncology2026

Explainable PET-Based Habitat Modeling for Predicting Postoperative Recurrence Risk in Invasive Lung Adenocarcinoma.

Cheng Zheng, Yujie Cai, Jiangfeng Miao, ChunFeng Sun

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cheng ZhengDepartment of Nuclear Medicine, Affiliated Hospital of Nantong University, Nantong, JiangSu, China.
Yujie CaiDepartment of Nuclear Medicine, Affiliated Hospital of Nantong University, Nantong, JiangSu, China.
Jiangfeng MiaoDepartment of Nuclear Medicine, Affiliated Hospital of Nantong University, Nantong, JiangSu, China.
ChunFeng SunDepartment of Nuclear Medicine, Affiliated Hospital of Nantong University, Nantong, JiangSu, China. sunchunfeng-nt@ntu.edu.cn.ORCID http://orcid.org/0000-0002-6219-909X

Funding

Jiangsu Provincial Research Hospital YJXYY202204-YSB18
6 · The paper itself

Abstract

purposePostoperative recurrence remains a major clinical challenge in patients with resectable invasive adenocarcinoma of the lung (IAC). Conventional PET-based parameters and whole-tumor radiomics may insufficiently reflect the spatial heterogeneity relevant to recurrence risk. This study aimed to develop and validate an interpretable radiomics model based on [

methodsThis retrospective study included 156 patients with pathologically confirmed IAC who underwent preoperative [

resultsThe habitat-based combined model demonstrated the highest predictive performance, achieving an area under the curve of 0.823 in the test cohort, with good calibration and clinical utility. Stratification based on model output showed significant differences in DFS between high- and low-risk groups, with P < 0.0001 in the training cohort and P = 0.018 in the test cohort.

conclusionThis PET-based habitat radiomics model provides a noninvasive and interpretable tool for preoperative prediction of postoperative recurrence in IAC. By accurately identifying patients at high risk of recurrence and reduced DFS, the model may support risk-adapted decision-making for postoperative management.

Indexed as

Adenocarcinoma of LungLung NeoplasmsNeoplasm Recurrence, LocalPositron-Emission TomographyPositron Emission Tomography Computed TomographyAgedFemaleFluorodeoxyglucose F18Follow-Up StudiesHumansMaleMiddle AgedNeoplasm InvasivenessPrognosisRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18Radiopharmaceuticals18F-FDG PET/CTHabitatInvasive lung adenocarcinomaPrognosisRadiomics

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.